Global Protein Expression Systems Market Report Description:
Global protein expression systems market report gives comprehensive outlook on protein expression systems application and usage across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on protein expression systems market gives historical, current, and future market sizes (US$ Mn) on the basis of expression system, product type, application, end user and geographic regions. This report studies protein expression systems market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, protein expression systems market report includes the competition analysis with vividly illustrated the competition dashboard to assess the protein expression systems market competition. Moreover, PBI analyzed protein expression systems market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs. Key stakeholders of the protein expression systems market report include manufacturers, marketers, biotechnology companies, pharmaceutical companies, academia, and clinical research organizations, policy makers, and healthcare service providers who are engaged in usage and advocacy of protein expression systems.
Global Protein Expression Systems Market:
Global protein expression systems market was valued around US$ 1,350 Mn in 2016 and poised to grow around 9.0% CAGR over 2017-2023.
Competition Assessment
Key players profiles in the global protein expression systems market include:

  • Merck KGaA (Germany)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Becton, Dickinson & Company (U.S.)
  • Agilent Technologies, Inc. (U.S.)
  • QIAGEN N.V. (Netherlands)
  • Takara Bio Inc. (Japan)
  • Lonza Group Ltd. (Switzerland)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • GenScript Biotech Corporation (China)
  • Lucigen Corporation (U.S.)
  • Synthetic Genomics Inc. (U.S.)
  • Promega Corporation (U.S.)
  • New England Biolabs, Inc. (U.S.)

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Detailed Segmentation

By Expression System

  • ·Yeast Expression
  • ·Insect Expression
  • ·Cell-Free Expression
  • ·Bacterial Expression
  • ·Algal Expression
  • ·Mammalian Expression

By Product

  • ·Systems
  • ·Reagents
  • ·Services

By Application

  • ·Industrial Proteins
  • ·Research
  • ·Therapeutic Proteins

By End User

  • ·Biotechnology Companies
  • ·Pharmaceutical Companies
  • ·Academia
  • ·Clinical Research Organizations


  • ·North America
  • U.S
  • Canada
  • ·Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe
  • ·Asia-Pacific
  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific
  • ·Latin America
  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America
  • ·Middle East and Africa (MEA)
  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA